المؤلفون: Gatzoulis, M.A., Landzberg, M., Beghetti, M., Berger, R.M., Efficace, M., Gesang, S., He, J., Papadakis, K., Pulido, T., Galiè, N.

المساهمون: MAESTRO Study Investigators

المصدر: Circulation, vol. 139, no. 1, pp. 51-63

مصطلحات موضوعية: Adolescent, Adult, Aged, Aged, 80 and over, Antihypertensive Agents/adverse effects, Antihypertensive Agents/therapeutic use, Biomarkers/blood, Child, Double-Blind Method, Down Syndrome/complications, Eisenmenger Complex/complications, Eisenmenger Complex/diagnostic imaging, Eisenmenger Complex/physiopathology, Endothelin Receptor Antagonists/adverse effects, Endothelin Receptor Antagonists/therapeutic use, Exercise Tolerance/drug effects, Female, Hemodynamics/drug effects, Humans, Hypertension, Pulmonary/diagnostic imaging, Hypertension, Pulmonary/drug therapy, Hypertension, Pulmonary/etiology, Hypertension, Pulmonary/physiopathology, Male, Middle Aged, Natriuretic Peptide, Brain/blood, Peptide Fragments/blood, Pulmonary Artery/drug effects, Pulmonary Artery/physiopathology, Pyrimidines/adverse effects, Pyrimidines/therapeutic use, Recovery of Function, Sulfonamides/adverse effects, Sulfonamides/therapeutic use, Time Factors, Treatment Outcome, Walk Test, Young Adult, Down syndrome, Eisenmenger syndrome, congenital heart disease, endothelin receptor antagonist, macitentan, pulmonary arterial hypertension

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______1900::bfe35a2b36e413c7337ccb8cf1df5ac1
https://serval.unil.ch/notice/serval:BIB_2B3253EE0026